- Review: Aspirin reduces CAD events in persons with no history of cardiovascular disease, but it increases gastrointestinal bleeding. Jain, Meera; Rosenberg, Mark // ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p6
Provides information on a study that examined the benefits and harms of aspirin use to prevent coronary artery disease events in persons with no history of cardiovascular disease. Data sources; Study selection; Data extraction; Main results; Conclusions.
- The endothelium: a new target for therapy. Cooke, J.P. // Vascular Medicine;2000, Vol. 5 Issue 1, p49
At one time considered merely a monolayer of cells lining the vascular conduit, the endothelium has emerged recently as an organ with functions as complex as any in the body. A highly active regulatory organ, the endothelium senses and assesses the hemodynamic, humoral, and inflammatory signals...
- Selective COX-2 inhibition improves endothelial function in coronary artery disease. Prabhakaran, Dorairaj; Anand, Sonia S // Vascular Medicine;2003, Vol. 8 Issue 1, p63
Question: What are the effects of celecoxib, a selective COX-2 inhibitor on endothelial function? Population: Fourteen male patients (46ï¿½77 years) with severe coronary artery disease and chronic stable angina who did not have a coronary revascularization procedure three months prior to...
- MR Angiography to Assess Coronary Artery Disease. Zepf, Bill // American Family Physician;7/1/2002, Vol. 66 Issue 1, p156
Presents information on a prospective, multicenter, international study to evaluate the clinical usefulness of magnetic resonance angiography (MRA) in the diagnosis of coronary heart disease. Background on invasive and noninvasive techniques in identifying coronary artery disease; Reliability...
- Obesity and Heart Disease: The Last Great Risk Factor? Rippe, James M. // Nutrition in Clinical Care;Jan/Feb98 Supplement 1, Vol. 1 Issue 1, p1
Focuses on the relationship of obesity and coronary heart disease (CHD) in the United States. Consideration of obesity as a risk factor for CHD; Percentage of obese adult population in the country; Increase of the risk for the development of CHD.
- Obesity as a Risk Factor for Heart Disease: An Overview. Rippe, James M. // Nutrition in Clinical Care;Jan/Feb98 Supplement 1, Vol. 1 Issue 1, p3
Presents an overview related to the relationship of obesity with coronary heart disease (CHD) in the United States. Prevalence of obesity in the country; Consideration of obesity as a strong and independent factor for CHD; Promotion of the clustering of multiple CHD risk factors due to obesity.
- Combined Endovascular Treatment of a Descending Thoracic Aortic Aneurysm and Off-Pump Myocardial Revascularization. Moura, Marcelo R.L.; Melissano, Germano; Maisano, Francesco; Marone, Enrico M.; Civilini, Efrem; Alfieri, Ottavio; Chiesa, Robert // Vascular & Endovascular Surgery;Jul/Aug2002, Vol. 36 Issue 4, p305
Presents a case study of a 76-year-old man with severe coronary artery disease and a thoracic aneurysm. Background on the incidence of aneurysmatic disease of the thoracic aorta; Medical history of the patient; Diagnosis and treatment.
- Introduction. T�th, Peter P. // Journal of Family Practice;Nov2009 Supplement, Vol. 58, pS17
The article discusses various reports published within the issue, including a pathogenesis update of atherosclerosis, a review on the new biomarkers or cardiovascular risk, and the supporting data on the practice of low-density lipoprotein cholesterol (LDL-C) objectives in determining patients...
- No adequate predictors to guide the treatment of post-TIA stroke. // Modern Medicine;Nov94, Vol. 62 Issue 11, p63
Presents an abstract of an article entitled `Factors Affecting Survival and Occurrence of Stroke in Patients With Transient Ischemic Attacks,' by B.A. Evans, J.D. Sciks and J.P. Whisnant in the May 1994 issue of the `Mayo Clinical Proceedings,' about the lack of adequate predictors to guide the...
- ...and, long term, it improves survival for those with heart disease. // Modern Medicine;Feb95, Vol. 63 Issue 2, p46
Presents an abstract of the article `Randomized Trial of Cholesterol Lowering in 4,444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4s),' by the Scandinavian Simvastatin Survival Study Group from the periodical `The Lancet,' dated November 19, 1994.